A detailed history of Harbour Investments, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 1,364 shares of MRNA stock, worth $92,779. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,364
Previous 1,399 2.5%
Holding current value
$92,779
Previous $149,000 8.05%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$101.21 - $166.61 $3,542 - $5,831
-35 Reduced 2.5%
1,364 $161,000
Q1 2024

Jul 22, 2024

BUY
$85.37 - $115.44 $1,109 - $1,500
13 Added 0.94%
1,399 $149,000
Q4 2023

Feb 16, 2024

SELL
$69.51 - $104.43 $18,976 - $28,509
-273 Reduced 16.46%
1,386 $137,000
Q3 2023

Nov 15, 2023

SELL
$96.41 - $126.61 $14,750 - $19,371
-153 Reduced 8.44%
1,659 $171,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $9,717 - $13,163
82 Added 4.74%
1,812 $220,000
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $5,019 - $7,289
37 Added 2.19%
1,730 $265,000
Q4 2022

Feb 15, 2023

SELL
$118.38 - $210.04 $44,274 - $78,554
-374 Reduced 18.09%
1,693 $304,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $4,099 - $6,180
35 Added 1.72%
2,067 $295,000
Q4 2021

Feb 16, 2022

SELL
$225.82 - $368.51 $1.51 Million - $2.46 Million
-6,677 Reduced 76.67%
2,032 $516,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $113,390 - $247,564
-511 Reduced 5.54%
8,709 $3.35 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $216,430 - $391,476
-1,666 Reduced 15.3%
9,220 $2.17 Million
Q1 2021

Aug 17, 2021

BUY
$109.18 - $185.98 $1.17 Million - $1.99 Million
10,720 Added 6457.83%
10,886 $1.43 Million
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $18,123 - $30,872
166 New
166 $22,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.